前列腺影像报告和数据系统第2版对MRI诊断前列腺癌包膜外侵犯的影响
本研究纳入210例临床局限性前列腺癌患者,对比PI-RADSv1与PI-RADSv2评估包膜外侵犯(ECE)的诊断效能。PI-RADSv2较v1提高了阴性预测值(96.3-97.1% vs 84.9-89.1%)和观察者间一致性(kappa 0.781 vs 0.511),但阳性预测值较低、过度分期值得关注,活检Gleason评分可能有互补作用。
要点
- PI-RADSv2评估ECE的阴性预测值达96.3-97.1%,高于PI-RADSv1的84.9-89.1%。
- PI-RADSv2观察者间kappa值为0.781,高于PI-RADSv1的0.511。
- 无形态学ECE征象时,肿瘤-包膜接触长度大于10 mm为最佳截断值。
核心结论
- PI-RADSv2减少ECE低估并提高观察者间一致性,但过度分期值得关注,活检Gleason评分可能有助于减少过度分期。
研究设计与样本
- 回顾性研究,纳入210例临床局限性前列腺癌患者,均行MRI检查和根治性前列腺切除术,由两名阅片者独立判读。
关键影像表现/征象
- PI-RADSv1采用5分法ECE风险评分。
- PI-RADSv2的ECE标准包括形态学特征和肿瘤-包膜接触长度(CL)大于10 mm。
诊断标准与关键数值
- ECE见于56例患者(26.7%)。
- PI-RADSv1以风险评分3分及以上为阈值时诊断准确率最高。
- 该阈值下PI-RADSv1和PI-RADSv2阳性分别为21.0-34.3%和49.0-51.4%的患者。
- PI-RADSv2阴性预测值96.3-97.1%,高于PI-RADSv1的84.9-89.1%(P=0.003和0.021,分别对应两名阅片者)。
- PI-RADSv2阳性预测值49.1-50.5%,低于PI-RADSv1的56.9-70.5%(P=0.025和0.300,分别对应两名阅片者)。
临床应用与阅片要点
- PI-RADSv2判为ECE阳性而PI-RADSv1判为阴性的患者中,活检Gleason评分7分及以下者73.3-74.1%被过度分期,8分及以上者35.7-44.4%被过度分期。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The purpose of this study is to validate the Prostate Imaging Reporting and Data System, version 2 (PI-RADSv2), in assessing extracapsular extension (ECE), compared with PI-RADS, version 1 (PI-RADSv1).
MATERIALS AND METHODS: A total of 210 patients with clinically localized prostate cancer underwent MRI and radical prostatectomy. Two readers independently interpreted the MR images. In PI-RADSv1, 5-point ECE risk scoring was used. In PI-RADSv2, ECE criteria included morphologic features and a tumor-capsule contact length (CL) greater than 10 mm. The diagnostic performance of each PI-RADS version and the cutoff CL were evaluated.
RESULTS: ECE was found in 56 patients (26.7%). In PI-RADSv1, maximal accuracy was achieved with a risk score of 3 or greater. At this threshold, positive findings on PI-RADSv1 and PI-RADSv2 were identified in 21.0-34.3% and 49.0-51.4% of patients, respectively. Compared with PI-RADSv1, PI-RADSv2 had higher negative predictive values (84.9-89.1% vs 96.3-97.1%, respectively; p = 0.003 and 0.021, for each reader). PI-RADSv1 and PI-RADSv2 had positive predictive values of 56.9-70.5% and 49.1-50.5%, respectively (p = 0.025 and 0.300, respectively). Interobserver kappa values for PI-RADSv1 and PI-RADSv2 were 0.511 and 0.781, respectively. The best cutoff CL was greater than 10 mm among patients without morphologic features of ECE. For patients positive for ECE on the basis of PI-RADSv2 but not PI-RADSv1, 73.3-74.1% of prostate cancer cases with a biopsy Gleason score of 7 or less and 35.7-44.4% of cases with a biopsy Gleason score of 8 or higher were overstaged.
CONCLUSION: PI-RADSv2 reduces understaging and improves interobserver agreement in ECE assessment. However, overstaging is a concern, and the biopsy Gleason score may have a complementary role in reducing overstaging.
引用
- Matsuoka Y, Ishioka J, Tanaka H, et al. Impact of the Prostate Imaging Reporting and Data System, Version 2, on MRI Diagnosis for Extracapsular Extension of Prostate Cancer. AJR Am J Roentgenol. 2017. PMID: 28570124. doi:10.2214/AJR.16.17163
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。